Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real‐world study

BACKGROUND: Lymphoid neoplasms treatment has recently been renewed to increase antitumor efficacy and conventional chemotherapies toxicities. Limited data have been published about the infection risk associated with these new drugs, therefore this study analyzes the infectious complications in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefania Infante, Maria, Fernández‐Cruz, Ana, Núñez, Lucia, Carpio, Cecilia, Jiménez‐Ubieto, Ana, López‐Jiménez, Javier, Vásquez, Lourdes, Del Campo, Raquel, Romero, Samuel, Alonso, Carmen, Morillo, Daniel, Prat, Margarita, Luis Plana, José, Villafuerte, Paola, Bastidas, Gabriela, Bocanegra, Ana, Serna, Ángel, De Nicolás, Rodrigo, Marquet, Juan, Mas‐Ochoa, Carmen, Cordoba, Raúl, García‐Suárez, Julio, Comai, Alessandra, Martín, Xavier, Bastos‐Oreiro, Mariana, Seri, Cristina, Navarro‐Matilla, Belén, López‐Guillermo, Armando, Martínez‐López, Joaquín, Ángel Hernández‐Rivas, José, Ruiz‐Camps, Isabel, Grande, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559487/
https://www.ncbi.nlm.nih.gov/pubmed/34558211
http://dx.doi.org/10.1002/cam4.4293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559487/
https://www.ncbi.nlm.nih.gov/pubmed/34558211
http://dx.doi.org/10.1002/cam4.4293

Ejemplares similares